Skip to main content
Log10

Log10

AI platform for life sciences document generation

About Log10

Log10's Everest is an AI-powered platform specifically designed for life sciences companies, including pharma, biotech, MedTech, CROs, and consultancies. The tool automates the creation of complex regulatory, clinical, and strategic documents that typically take weeks to produce. Everest generates submissions like 510(k)s, INDs, Clinical Study Reports, Clinical Evaluation Reports, and eCTD modules in minutes while maintaining compliance standards. The platform uses agentic AI workflows to transform team insights into scalable document solutions. It offers white-label capabilities, allowing CROs and consultancies to rebrand the technology as their own AI-powered service offering. Merigold's Bloom AI demonstrates this partnership model in action, focusing on imaging documentation for clinical trials. The platform is specifically tailored to meet the stringent requirements of life sciences documentation, covering regulatory affairs, clinical operations, and commercial strategy needs.

Our Review

Log10's Everest represents a highly specialized solution for a niche but critical market. The platform's laser focus on life sciences documentation is both its greatest strength and limitation. For regulatory affairs professionals and clinical teams drowning in document production workflows, Everest offers compelling value—testimonials cite reducing CER production from weeks to under an hour. The breadth of document types supported is impressive, covering regulatory submissions, clinical trial documentation, and strategic planning materials. The white-label partnership model is innovative, enabling service providers to scale without building internal AI capabilities, as demonstrated by Merigold's Bloom AI implementation. However, the platform appears enterprise-focused with no transparent pricing, which may limit accessibility for smaller organizations. The website emphasizes compliance and accuracy but lacks detailed technical specifications about how the AI ensures regulatory standards are met. User experience details are minimal, and there's no information about trial access or hands-on evaluation options. The demo-first approach suggests a high-touch sales process typical of enterprise software. For its target audience, Everest could deliver significant efficiency gains, but the barrier to entry and specialized nature mean it won't suit general-purpose document needs.

Pros & Cons

Pros

●Highly specialized for life sciences regulatory and clinical documentation requirements
●Dramatically reduces document production time from weeks to hours according to user testimonials
●White-label partnership model enables CROs and consultancies to offer AI services without internal development
●Comprehensive document coverage across regulatory, clinical, and strategic use cases
●Built-in compliance considerations for regulated industries like pharma and MedTech

Cons

●No transparent pricing information available, requiring sales contact for costs
●Extremely niche focus limits applicability outside life sciences sector
●Lacks detail on how AI ensures regulatory compliance and accuracy
●No apparent trial or self-service option for evaluation before committing to demos

Best For

Pharmaceutical and biotech companies managing regulatory submissionsMedTech companies requiring EU MDR-compliant Clinical Evaluation ReportsCROs and consultancies seeking to scale documentation services with AIRegulatory affairs teams producing 510(k), IND, or eCTD submissionsClinical operations teams creating protocols, study reports, and monitoring documentation

Contact sales

ENTERPRISE

Visit Log10 →